in this issue
Markets :: Specialty Chemicals :: Personal Care
Innospec earnings fall despite rising sales
May 7, 2014 | Vincent Valk
Innospec has reported first-quarter net income down 6% year-on-year (YOY), to $16.9 million, on sales up 11%, to $220.7 million. Adjusted earnings, excluding some foreign currency and tax impacts, declined 25% YOY, to 54 cts/share. Earnings were hit by weak results in octane additives, which had nearly zero sales, since the segment’s product has been phased out in many markets. “The underlying performance of our core businesses continued on track in the first quarter, and the strategic acquisitions we made last year are delivering to our...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee